Lung Cancer

1

Editorial Board

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 61 KB

english, 2012

2

Rising incidence of adenocarcinoma of the lung in Canada

Jiang, XiaoHong, de Groh, Margaret, Liu, Shiliang, Liang, Hongbo, Morrison, Howard

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 653 KB

english, 2012

4

A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer

Clément-Duchêne, Christelle, Natale, Ronald B., Jahan, Thierry, Krupitskaya, Yelena, Osarogiagbon, Raymond, Sanborn, Rachel E., Bernstein, Eric D., Dudek, Arkadiusz Z., Latz, Jane E., Shi, Peipei, Wak

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 300 KB

english, 2012

5

Comparative study of solitary thin-walled cavity lung cancer with computed tomography and pathological findings

Xue, XinYing, Wang, PeiLan, Xue, QingLiang, Wang, Na, Zhang, LiNa, Sun, JunPing, Wang, KaiFei, Yang, Bing, Wang, JianXin

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 1.31 MB

english, 2012

6

Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype

Metro, Giulio, Chiari, Rita, Duranti, Simona, Siggillino, Annamaria, Fischer, Matthias J., Giannarelli, Diana, Ludovini, Vienna, Bennati, Chiara, Marcomigni, Luca, Baldi, Alice, Giansanti, Michele, Mi

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 568 KB

english, 2012

7

Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: A retrospective study of 300 patients

Nagy-Mignotte, Hélène, Guillem, Pascale, Vignoud, Lucile, Coudurier, Marie, Vesin, Aurélien, Bonneterre, Vincent, Toffart, Anne-Claire, Sakhri, Linda, Brambilla, Christian, Brambilla, Elisabeth, Timsi

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 453 KB

english, 2012

8

Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer

Spigel, David R., Anthony Greco, F., Waterhouse, David M., Shipley, Dianna L., Zubkus, John D., Bury, Martin J., Webb, Charles D., Hart, Lowell L., Gian, Victor G., Infante, Jeffrey R., Burris, Howard

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 231 KB

english, 2012

9

Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: A literature-based meta-analysis of 24 trials

Petrelli, Fausto, Borgonovo, Karen, Cabiddu, Mary, Lonati, Veronica, Barni, Sandro

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 521 KB

english, 2012

10

Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT

Wang, Jingbo, Mahasittiwat, Pawinee, Wong, Ka Kit, Quint, Leslie E., Kong, Feng-Ming (Spring)

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 540 KB

english, 2012

11

Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium

Campbell, Nicholas P., Kunnavakkam, Rangesh, Leighl, Natasha, Vincent, Mark D., Gandara, David R., Koczywas, Marianna, Gitlitz, Barbara J., Agamah, Edem, Thomas, Sachdev P., Stadler, Walter M., Vokes,

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 381 KB

english, 2012

12

Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response

Fujii, Masanori, Hotta, Katsuyuki, Takigawa, Nagio, Hisamoto, Akiko, Ichihara, Eiki, Tabata, Masahiro, Tanimoto, Mitsune, Kiura, Katsuyuki

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 208 KB

english, 2012

13

A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer

Kawahara, Akihiko, Taira, Tomoki, Azuma, Koichi, Tominaga, Masaki, Hattori, Satoshi, Kawahara, Mayuko, Abe, Hideyuki, Yamaguchi, Tomohiko, Akiba, Jun, Takamori, Shinzo, Hayashi, Akihiro, Kage, Masayos

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 641 KB

english, 2012

14

Disappearance of an activated EGFR mutation after treatment with EGFR tyrosine kinase inhibitors

Honda, Yoshihiro, Takigawa, Nagio, Fushimi, Soichiro, Ochi, Nobuaki, Kubo, Toshio, Ozaki, Saeko, Tanimoto, Mitsune, Kiura, Katsuyuki

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 1.35 MB

english, 2012

15

An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases

Sandler, Alan, Hirsh, Vera, Reck, Martin, von Pawel, Joachim, Akerley, Wallace, Johnson, David H.

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 243 KB

english, 2012

16

Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy

Fischer, Bruno, Frei, Claudia, Moura, Ubiratan, Stahel, Rolf, Felley-Bosco, Emanuela

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 722 KB

english, 2012

17

EGFR mutations and mucoepidermoid carcinoma: Putative significance in differing populations

O’Neill, Iain D.

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 111 KB

english, 2012

18

A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer

Grønberg, Bjørn H., Ciuleanu, Tudor, Fløtten, Øystein, Knuuttila, Aija, Abel, Edvard, Langer, Seppo W., Krejcy, Kurt, Liepa, Astra M., Munoz, Maria, Hahka-Kemppinen, Marjo, Sundstrøm, Stein

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 525 KB

english, 2012

19

Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC

Grimminger, Peter P., Maus, Martin K.H., Schneider, Paul M., Metzger, Ralf, Hölscher, Arnulf H., Sugita, Hirofumi, Danenberg, Peter V., Alakus, Hakan, Brabender, Jan

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 357 KB

english, 2012

20

Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed–carboplatin

Tiseo, Marcello, Giovannetti, Elisa, Tibaldi, Carmelo, Camerini, Andrea, Di Costanzo, Francesco, Barbieri, Fausto, Burgers, Jacobus A., Vincent, Andrew, Peters, Godefridus J., Smit, Egbert F., Ardizzo

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 285 KB

english, 2012

21

The association of elevated 2′,5′-oligoadenylate-dependent RNase L with lung cancer correlated with deficient enzymatic activity and decreased capacity of RNase L dimerization

Yin, Huijing, Zhou, Aimin, Dai, Yalei

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 1.62 MB

english, 2012

22

Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer

Okamura, Kyoko, Harada, Taishi, Wang, Shuo, Ijichi, Kayo, Furuyama, Kazuto, Koga, Takaomi, Okamoto, Tatsuro, Takayama, Koichi, Yano, Tokujiro, Nakanishi, Yoichi

Journal:

Lung Cancer

Year:

2012

Language:

english

File:

PDF, 628 KB

english, 2012

Volume 78; Issue 1

Editorial Board

Contents

Rising incidence of adenocarcinoma of the lung in Canada

A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer

Comparative study of solitary thin-walled cavity lung cancer with computed tomography and pathological findings

Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype

Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: A retrospective study of 300 patients

Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer

Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: A literature-based meta-analysis of 24 trials

Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT

Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium

Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response

A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer

Disappearance of an activated EGFR mutation after treatment with EGFR tyrosine kinase inhibitors

An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases

Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy

EGFR mutations and mucoepidermoid carcinoma: Putative significance in differing populations

A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer

Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC

Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed–carboplatin

The association of elevated 2′,5′-oligoadenylate-dependent RNase L with lung cancer correlated with deficient enzymatic activity and decreased capacity of RNase L dimerization

Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer